Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X₁ receptor activation

Keyphrases

• Angiotensin II (Ang II) 100%
• Hypertensive Rats 100%
• Receptor Activation 100%
• Pentosan Polysulfate 100%
• P2X Receptors 100%
• Renal Autoregulation 100%
• Hypertension 27%
• Vasoconstriction 18%
• Perfusion Pressure 18%
• Methylene 18%
• Renal Injury 18%
• Afferent Arteriole 18%
• Induced Hypertension 9%
• Inflammation 9%
• Transforming Growth Factor-β 9%
• Receptor Agonist 9%
• Microvascular Reactivity 9%
• Human Subjects 9%
• Inflammatory Process 9%
• Nephron 9%
• P2 Receptors 9%
• Inflammatory Factors 9%
• α-smooth muscle Actin (α-SMA) 9%
• Anti-inflammatory Agents 9%
• Animal Subjects 9%
• Persistent Hypertension 9%

Neuroscience

• Autoregulation 100%
• Pentosan Polysulfate 100%
• Purinergic P2X1 Receptor 100%
• Adenosine Triphosphate 57%
• Behavior (Neuroscience) 42%
• Arteriole 28%
• Staining Technique 14%
• Fibrinogen 14%
• Receptor Agonists 14%
• Transforming Growth Factor 14%
• In Vitro 14%
• Nephron 14%
• P2 Receptor 14%
• Smooth Muscle Actin 14%
• Anti-Inflammatory Agent 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Pentosan Polysulfate 100%
• Purinergic P2X1 Receptor 100%
• Adenosine Triphosphate 57%
• Inflammation 28%
• Carbene 28%
• Kidney Injury 28%
• Transforming Growth Factor 14%
• Fibrinogen 14%
• Receptor Agonist 14%
• Purinergic P2 Receptor 14%
• Antiinflammatory Agent 14%
• Smooth Muscle Actin 14%
• Human 14%